INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA

Published:2016-09 Issue:9 Volume:36 Page:1640-1645
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Andrade Gabriel Costa de,Dias João Rafael de Oliveira,Maia André,Farah Michel Eid,Meyer Carsten H.,Rodrigues Eduardo Büchele

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference18 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030;Shaw;Diabetes Res Clin Pract,2010

2. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes;Klein;Ophthalmology,2009

3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus.;N Engl J Med,1993

4. Intensive blood-glucose control with sulphonylureas or insulin com- pared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).;Lancet,1998

5. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63);Gray;BMJ,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectral-domain optical coherence tomography combined with electroretinography in the assessment of conbercept for neovascular age-related macular degeneration: a preliminary study;Frontiers in Neuroscience;2023-04-25

2. Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting;Clinical Ophthalmology;2023-04

3. Complications of Ziv-Aflibercept in Choroidal and Retinal Vascular Diseases;Open Journal of Ophthalmology;2023

4. Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?;Expert Opinion on Biological Therapy;2022-07-17

5. Use of ziv-aflibercept in diabetic macular edema in a Ghanaian population;Eye;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3